Clinical Trial Update: An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)

View source ↗

Summary

An observational registry assessing real-world outcomes and safety of Norditropin (somatropin) in children and adults treated for growth hormone-related disorde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Hypopituitarism
• Pituitary Dwarfism

Drugs mentioned

• Norditropin (somatropin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Growth Hormone Disorder, Pituitary Dwarfism | Status: COMPLETED